Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Influenza

  Free Subscription


18.03.2019

1 BMJ
1 Drugs
3 Epidemiol Infect
1 J Immunol
3 J Virol
1 PLoS Comput Biol
2 PLoS One
1 Proc Natl Acad Sci U S A
3 Vaccine
2 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ

  1. PEBODY RG, Zambon M, Ramsay M
    Flu vaccines: an annual challenge.
    BMJ. 2018;361:k2705.
    PubMed     Text format    


    Drugs

  2. HEO YA
    Baloxavir: First Global Approval.
    Drugs. 2018;78:693-697.
    PubMed     Text format     Abstract available


    Epidemiol Infect

  3. VILCHES TN, Jaberi-Douraki M, Moghadas SM
    Risk of influenza infection with low vaccine effectiveness: the role of avoidance behaviour.
    Epidemiol Infect. 2019;147:e75.
    PubMed     Text format     Abstract available

  4. KORSUN NS, Angelova SG, Trifonova IT, Georgieva IL, et al
    Predominance of influenza B/Yamagata lineage viruses in Bulgaria during the 2017/2018 season.
    Epidemiol Infect. 2019;147:e76.
    PubMed     Text format     Abstract available

  5. PAN M, Yang HP, Jian J, Kuang Y, et al
    Association of meteorological factors with seasonal activity of influenza A subtypes and B lineages in subtropical western China.
    Epidemiol Infect. 2019;147:e72.
    PubMed     Text format     Abstract available


    J Immunol

  6. ZHOU AC, Batista NV, Watts TH
    4-1BB Regulates Effector CD8 T Cell Accumulation in the Lung Tissue through a TRAF1-, mTOR-, and Antigen-Dependent Mechanism to Enhance Tissue-Resident Memory T Cell Formation during Respiratory Influenza Infection.
    J Immunol. 2019 Mar 13. pii: jimmunol.1800795. doi: 10.4049/jimmunol.1800795.
    PubMed     Text format     Abstract available


    J Virol

  7. SIEGERS JY, van de Bildt MWG, Lin Z, Leijten LM, et al
    Viral Factors Important for Efficient Replication of Influenza A Viruses in Cells of the Central Nervous System.
    J Virol. 2019 Mar 13. pii: JVI.02273-18. doi: 10.1128/JVI.02273.
    PubMed     Text format     Abstract available

  8. ALNAJI FG, Holmes JR, Rendon G, Vera JC, et al
    Sequencing framework for the sensitive detection and precise mapping of defective interfering particle-associated deletions across influenza A and B viruses.
    J Virol. 2019 Mar 13. pii: JVI.00354-19. doi: 10.1128/JVI.00354.
    PubMed     Text format     Abstract available

  9. NOGALES A, Avila-Perez G, Rangel-Moreno J, Chiem K, et al
    A novel fluorescent and bioluminescent Bi-Reporter influenza A virus (BIRFLU) to evaluate viral infections.
    J Virol. 2019 Mar 13. pii: JVI.00032-19. doi: 10.1128/JVI.00032.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  10. VOLZ EM, Siveroni I
    Bayesian phylodynamic inference with complex models.
    PLoS Comput Biol. 2018;14:e1006546.
    PubMed     Text format     Abstract available


    PLoS One

  11. NUVEY FS, Edu-Quansah EP, Kuma GK, Eleeza J, et al
    Evaluation of the sentinel surveillance system for influenza-like illnesses in the Greater Accra region, Ghana, 2018.
    PLoS One. 2019;14:e0213627.
    PubMed     Text format     Abstract available

  12. DODD CN, de Ridder M, Huang WT, Weibel D, et al
    Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.
    PLoS One. 2018;13:e0204799.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  13. FURUSE Y
    Analysis of research intensity on infectious disease by disease burden reveals which infectious diseases are neglected by researchers.
    Proc Natl Acad Sci U S A. 2018 Dec 31. pii: 1814484116.
    PubMed     Text format     Abstract available


    Vaccine

  14. SEKIYA T, Mifsud EJ, Ohno M, Nomura N, et al
    Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
    Vaccine. 2019 Mar 8. pii: S0264-410X(19)30264.
    PubMed     Text format     Abstract available

  15. TING-HUI-LIN, Chia MY, Lin CY, Yeh YQ, et al
    Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development.
    Vaccine. 2019;37:1897-1903.
    PubMed     Text format     Abstract available

  16. THORRINGTON D, van Leeuwen E, Ramsay M, Pebody R, et al
    Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly.
    Vaccine. 2019 Mar 11. pii: S0264-410X(19)30293.
    PubMed     Text format     Abstract available


    Virology

  17. TAKIZAWA N, Ogura Y, Fujita Y, Noda T, et al
    Local structural changes of the influenza A virus ribonucleoprotein complex by single mutations in the specific residues involved in efficient genome packaging.
    Virology. 2019;531:126-140.
    PubMed     Text format     Abstract available

  18. YUMINE N, Matsumoto Y, Ohta K, Fukasawa M, et al
    Claudin-1 inhibits human parainfluenza virus type 2 dissemination.
    Virology. 2019;531:93-99.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: